ClinicalTrials.gov
public full text
Public Domain
Penn Microbiome Therapy for Recurrent Clostridium Difficile Infection
This is a randomized, open label, comparative, Phase II study to determine which dose of fecal microbiota transplant using Penn Microbiome Therapy (PMT) products is most effective in treating and preventing recurrence of Clostridium difficile infection (C diff).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Reduction of C-Difficile Infection Using Stool Transplant#909069
- IMT for Primary Clostridium Difficile Infection#1030950
- Intestinal Microbiota Transplantation in Patients With Chronic Heart Failure#843762
- Fecal Microbiota Transplantation in Recurrent or Refractory Clostridium Difficile Colitis#1073468
- Microbiome-based therapeutics for <i>Clostridioides difficile</i> infection: additive, subtractive, and modulatory strategies in modern clinical practice#676277
Record · ID 888358
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive